
Palrise 40mg Injection
Marketer
Alarius Healthcare
Salt Composition
Pantoprazole (40mg)
Overview Palrise 40mg Injection
AcidGard 40mg Injection diminishes gastric acid production. It treats acid-related gastrointestinal disorders including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, alleviating symptoms and fostering healing. AcidGard 40mg Injection also prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this intravenous medication is administered by a healthcare professional only when deemed superior to oral administration. Dosage is individualized based on your condition and response. Treatment duration is determined by your physician; continue as prescribed, even with rapid symptom resolution. Optimize treatment by consuming smaller, more frequent meals and avoiding caffeine, spicy foods, and high-fat diets. Common side effects include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). While typically mild, persistent or bothersome effects warrant medical attention. Prolonged use may increase side effect risk; usage exceeding one year elevates fracture risk, especially at higher doses. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. AcidGard 40mg Injection is contraindicated in certain individuals. Inform your physician of severe hepatic impairment, concurrent HIV medication use, prior allergic reactions to similar medications, or pre-existing osteoporosis before use. Pregnant or lactating women should seek medical advice. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Palrise 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Palrise 40mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Palrise 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Palrise 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
How Palrise 40mg Injection works:
Axipump 40mg Injection, a proton pump inhibitor, decreases stomach acid production, thus alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Palrise 40mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Palrise 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible adverse effects prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Palrise 40mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
Palrise 40mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Palrise 40mg Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
For individuals with severe hepatic impairment, administration of Palrise 40mg Injection requires careful consideration. Dosage modification of Palrise 40mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Palrise 40mg Injection :
Omit a Palrise 40mg Injection dose? Seek medical advice immediately.
Facts to Know About Palrise 40mg Injection
| Label | Value |
|---|---|
| Type of Compound | Benzimidazole sulfoxide |
| Addiction potential | None. |
| Medication Classification | Digestive system |
| Mechanism of Action | Gastric acid secretion blockers |
